Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Fausa

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
Gut|March 1, 1997
Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern NorwayB Moum, A Ekbom, M H Vatn, et al.
Scandinavian Journal of Gastroenterology|November 15, 1997
Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93B Moum, A Ekbom, M H Vatn, et al.
The Journal of Experimental Medicine|July 1, 1993
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patientsK E Lundin, H Scott, T Hansen, et al.
Scandinavian Journal of Gastroenterology|April 1, 1996
Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of GastroenterologistsB Moum, M H Vatn, A Ekbom, et al.
Gut|October 16, 2002
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosisE Björnsson, K M Boberg, S Cullen, et al.
Gut|August 13, 2002
Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expressionI N Farstad, F-E Johansen, L Vlatkovic, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1990
Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonistsL Lundell, L Backman, P Ekström, et al.
The American Journal of Gastroenterology|March 1, 1995
Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter studyA Nilsson, A Danielsson, R Löfberg, et al.
Scandinavian Journal of Gastroenterology|March 1, 1991
Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidineL Lundell, L Backman, P Ekström, et al.
Scandinavian Journal of Gastroenterology|November 1, 2002
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentationK M Boberg, A Bergquist, S Mitchell, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Gut|March 1, 1997
Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern NorwayB Moum, A Ekbom, M H Vatn, et al.
Scandinavian Journal of Gastroenterology|November 15, 1997
Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93B Moum, A Ekbom, M H Vatn, et al.
The Journal of Experimental Medicine|July 1, 1993
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patientsK E Lundin, H Scott, T Hansen, et al.
Scandinavian Journal of Gastroenterology|April 1, 1996
Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of GastroenterologistsB Moum, M H Vatn, A Ekbom, et al.
Gut|October 16, 2002
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosisE Björnsson, K M Boberg, S Cullen, et al.
Gut|August 13, 2002
Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expressionI N Farstad, F-E Johansen, L Vlatkovic, et al.
Alimentary Pharmacology & Therapeutics|April 1, 1990
Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonistsL Lundell, L Backman, P Ekström, et al.
The American Journal of Gastroenterology|March 1, 1995
Olsalazine versus sulphasalazine for relapse prevention in ulcerative colitis: a multicenter studyA Nilsson, A Danielsson, R Löfberg, et al.
Scandinavian Journal of Gastroenterology|March 1, 1991
Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidineL Lundell, L Backman, P Ekström, et al.
Scandinavian Journal of Gastroenterology|November 1, 2002
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentationK M Boberg, A Bergquist, S Mitchell, et al.
Pageof 17